Abstract 5921: Correlation between MET amplification/overexpression status and response to MCLA-129 in advanced non-small-cell lung cancer (NSCLC): biomarker results from a phase 1 trial
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, First Affiliated Hospital of Xi'an Jiaotong University, ShenZhen People’s Hospital, First Hospital of China Medical University, First Affiliated Hospital of Zhengzhou University, Guangdong Provincial Hospital of Chinese Medicine, Affiliated Hospital of Qingdao University, First Affiliated Hospital of Soochow University, Second People’s Hospital of Yibin, Sun Yat-sen Memorial Hospital, Chongqing University, Chongqing Cancer Hospital, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Henan Cancer Hospital, Shandong Tumor Hospital, Hunan Cancer Hospital, Affiliated Hospital of Hebei University, Hebei University, Betta Pharmaceuticals (China)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409630750